Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

November 30, 2009

Conditions
Advanced Breast Cancer
Interventions
DRUG

Goserelin acetate

3.6 mg intramuscular depot injection given every 4 weeks

DRUG

Goserelin acetate

10.8 mg intramuscular depot injection given every 12 weeks

Trial Locations (14)

Unknown

Research Site, Prague

Research Site, Arkhangelsk

Research Site, Belgorod

Research Site, Kaliningarad

Research Site, Kazan, Tatarstan

Research Site, Moscow

Research Site, Ryazan

Research Site, Saint Petersburg

Research Site, Yaroslavl

Research Site, Dnipropetrovsk

Research Site, Donetsk

Research Site, Kharkiv

Research Site, Odesa

Research Site, Uzhhorod

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY